The Current Ratio as of December 2025 (TTM) for Modus Therapeutics Holding AB (publ) (MODTX.ST) is 5.98

According to Modus Therapeutics Holding AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 5.98. This represents a change of 166.90% compared to the average of 2.24 of the last 4 quarters.

Modus Therapeutics Holding AB (publ) (MODTX.ST) Historical Current Ratio (quarterly & annually)

How has MODTX.ST Current Ratio performed in the past?

The mean historical Current Ratio of Modus Therapeutics Holding AB (publ) over the last ten years is 4.64. The current 5.98 Current Ratio has changed 12.79% with respect to the historical average. Over the past ten years (40 quarters), MODTX.ST's Current Ratio was at its highest in in the September 2021 quarter at 20.29. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Modus Therapeutics Holding AB (publ) (MODTX.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Modus Therapeutics Holding AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Modus Therapeutics Holding AB (publ) (MODTX.ST) Average Current Ratio

How has MODTX.ST Current Ratio performed in the past?

The current Current Ratio of Modus Therapeutics Holding AB (publ) (MODTX.ST) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Modus Therapeutics Holding AB (publ) (MODTX.ST) Current Ratio vs. Peers

How is MODTX.ST’s Current Ratio compared to its peers?

Modus Therapeutics Holding AB (publ)’s Current Ratio is greater than ExpreS2ion Biotech Holding AB (publ) (1.98), greater than 2cureX AB (publ) (2.93), greater than Aino Health AB (publ) (0.43), greater than Guard Therapeutics International AB (publ) (4.87), greater than Episurf Medical AB (publ) (2.75), less than Stayble Therapeutics AB (publ) (7.18), greater than Simris Alg AB (publ) (0.17), greater than Fluicell AB (publ) (1.83), greater than Qlife Holding AB (publ) (0.83), greater than Lipigon Pharmaceuticals AB (publ) (5.95),

Build a custom stock screener for Modus Therapeutics Holding AB (publ) (MODTX.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Modus Therapeutics Holding AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Modus Therapeutics Holding AB (publ) (MODTX.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Modus Therapeutics Holding AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.